Manidipine dihydrochloride

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

BIBU 1361 dihydrochloride is a selective inhibitor of EGFR-kinase. Selectivity is exhibited over a range of other related tyrosine kinases. BIBU 1361 dihydrochloride blocks downstream signaling.

Bimatoprost-d 5 is a deuterium labeled Bimatoprost. Bimatoprost is a prostaglandin analog and is a topical hypotensive agent frequently used for treating ocular hypertension and glaucoma. Bimatoprost also has an antiadipogenic

This product is provided as delivered and specified by the issuing Pharmacopoeia. For further information and support, including product information leaflets, please go to the website of the issuing Pharmacopoeia .

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

Manidipine dihydrochloride

Manidipine dihydrochloride

Biochem/physiol Actions Manidipine is a dihydropyridine class calcium channel blocker (CCB) that exerits its antihypertensive activity via targeting both L-type and T-type calcium channels. In contrary to other dihydropyridines and

Biochem/physiol Actions Manidipine is a dihydropyridine class calcium channel blocker (CCB) that exerits its antihypertensive activity via targeting both L-type and T-type calcium channels. In contrary to other dihydropyridines and

InformationMirodenafil (SK-3530) dihydrochloride is an inhibitor of phosphodiesterase type 5 (PDE-5) that developed for the treatment of erectile dysfunction.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

PIPAMPERONE DIHYDROCHLORIDE